Insider Trading: Neurocrine Biosciences Inc (NBIX.O)

NBIX.O on Nasdaq

12.01USD
12:12pm EDT
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$11.75
Open
$12.06
Day's High
$12.12
Day's Low
$11.71
Volume
275,801
Avg. Vol
521,100
52-wk High
$12.85
52-wk Low
$6.25

Search Stocks
BVF PARTNERS L P Options Exercised: 0
Trade Date: Sunday, 9 Oct 2011 Price: 5.59
Title: Beneficial Owner of More than 10% Class Shares Held: 3,505,400
Type Traded: Indirect Net Change in Shares This Filing: 73,900

Institutional Holders

% Shares Owned: 85.99%
# of Holders: 144
Total Shares Held: 57,385,792
3 Mo. Net Change: 2,217,747
# New Positions: 25
# Closed Positions: 12
# Increased Positions: 73
# Reduced Positions: 51
# Net Buyers: 22

Officers & Directors

Name Age Since Current Position

William Rastetter

64 2011 Independent Chairman of the Board

Kevin Gorman

54 2008 President, Chief Executive Officer, Director

Timothy Coughlin

45 2006 Chief Financial Officer, Vice President

Haig Bozigian

54 2010 Senior Vice President - Pharmaceutical and Preclinical Development

Christopher O'Brien

55 Senior Vice President, Chief Medical Officer

Dimitri Grigoriadis

54 2007 Vice President - Research

Gary Lyons

62 2008 Independent Director

W. Thomas Mitchell

65 2002 Independent Director

Joseph Mollica

70 2011 Independent Director

Corinne Nevinny

53 2004 Independent Director

Richard Pops

50 1998 Independent Director

Stephen Sherwin

64 1999 Independent Director

Jane Sorensen

Investor Relations Officer
Search Stocks